Table 1.
Demographic and clinical characteristics of the study population.
| Overall |
Lockdown |
p-value | ||
|---|---|---|---|---|
| Before |
During |
|||
| n = 453 | n = 337 | n = 116 | ||
| Age, mean ± SD, years | 69.2 ± 10.6 | 68.9 ± 10.8 | 70.2 ± 10.1 | 0.242 |
| Age group, n (%) | ||||
| < 55 years | 40 (8.8) | 32 (9.5) | 8 (6.9) | 0.453 |
| 55–64 years | 99 (21.9) | 77 (22.8) | 22 (19.0) | 0.436 |
| 65–75 years | 181 (40.0) | 133 (39.5) | 48 (41.4) | 0.742 |
| > 75 years | 133 (29.4) | 95 (28.2) | 38 (32.8) | 0.348 |
| Female, n (%) | 125 (27.6) | 89 (26.4) | 36 (31.0) | 0.338 |
| Fontaine classification, n (%) | ||||
| Stage 3 | 177 (39.1) | 145 (43.0) | 32 (27.6) | 0.004 |
| Stage 4 | 276 (60.9) | 192 (57.0) | 84 (72.4) | 0.004 |
| In-hospital management, n (%) | ||||
| Medical therapy | 57 (12.6) | 43 (12.8) | 14 (12.1) | 1 |
| Urgent revascularization | 317 (70.0) | 249 (73.9) | 68 (58.6) | 0.003 |
| Urgent revascularization and amputation | 37 (8.2) | 22 (6.5) | 15 (12.9) | 0.047 |
| Medical therapy and amputation | 42 (9.3) | 23 (6.8) | 19 (16.4) | 0.005 |
| Revascularization, n (%) | 354 (78.2) | 271 (80.4) | 83 (61.5) | 0.001 |
| Revascularization group, n (%) | ||||
| Percutaneous | 275 (77.7) | 217 (80.1) | 58 (69.9) | 0.07 |
| Surgical | 73 (20.6) | 50 (18.5) | 23 (27.7) | 0.087 |
| Hybrid | 6 (1.7) | 4 (1.5) | 2 (2.4) | 0.628 |
| Amputation during hospital stay, n (%) | 79 (17.4) | 45 (13.4) | 34 (29.3) | < 0.001 |
Overall: all patients included in the study; Before: patients hospitalized during the 5 weeks before regional lockdown; During: patients hospitalized during the 5 weeks during the national lockdown; Hybrid: endovascular + surgical.